Clinical trial
Inhibition of Oral Tumorigenesis by Antitumor B
NCT04278989 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inhibition of Oral Tumorigenesis by Antitumor B
- Lead sponsor
- Medical College of Wisconsin
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 22, 2022
- Completion date
- June 5, 2025
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
squamous cell cancer of the oral cavity